$112.46 +2.69 (2.45%) Gilead Sciences Inc - NASDAQ

May. 27, 2015 | 04:00 PM
Key Statistics
Last Trade: 112.46
Trade Time: May 27 04:00 PM Eastern Daylight Time
Change: +2.69 (2.45%)
Prev Close: 109.77
Open: 110.34
Bid: 112.44
Ask: 112.46

Competitors

Ticker Name Volume % Change
ONTY Oncothyreon Inc 13.35M -3.73%
OPXA Opexa Therapeutics Inc 11.89M +34.81%
AMGN Amgen Inc 3.33M +0.90%
ENZN Enzon Pharmaceuticals Inc 3.30M +7.94%
PLX Protalix BioTherapeutics Inc 3.01M -4.63%

GILD Stock Analysis

Partner Headlines

  1. GlobeImmune Hep-B trial fails

    IBD | May. 27, 2015 | 19:02PM EST
  2. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 27, 2015 | 15:54PM EST
  3. Gilead-GlobeImmune Hepatitis B Drug Fails Trial

    IBD | May. 27, 2015 | 12:57PM EST
  4. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  5. Achillion

    IBD | May. 20, 2015 | 18:39PM EST
  6. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 13:52PM EST